The U.S. PTA balloon catheter market size is anticipated to reach USD 2.02 billion by 2030 and is anticipated to expand at a CAGR of 9.61% from 2024 to 2030, according to a new report by Grand View Research, Inc. The market is driven by several key factors, including the rising incidence of cardiovascular diseases and peripheral artery disease, the increasing popularity of minimally invasive procedures, and the geriatric population. According to the Population Reference Bureau, there will be a significant rise in the number of Americans aged 65 or above from 58 million in 2022 to 82 million by 2050. This indicates a 47% surge in the elderly population, accounting for a higher proportion of the overall population, rising from 17% to 23%.
The healthcare industry has been witnessing a significant increase in minimally invasive procedures. Medical professionals and patients are opting more for minimally invasive procedures such as percutaneous transluminal angioplasty (PTA) using balloon catheters. Such procedures have various benefits over traditional open surgeries, including faster recovery times, reduced discomfort, and lower risks of complications.
Technological advancements have been vital in driving innovation in PTA balloon catheters. The manufacturers continuously develop new catheter designs, materials, coatings, and delivery systems to improve performance, safety, and patient outcomes. Moreover, incorporating technologies such as drug-coated balloons and digital imaging significantly improved the effectiveness of PTA procedures.
Request a free sample copy or view report summary: U.S. PTA Balloon Catheter Market Report
The nylon segment held the largest market share of around 50% in 2023 owing to the strength and durability of the material, making it a preferred choice for balloon catheter.
The polyurethane segment is expected to grow at the fastest CAGR over the forecast period owing to the unique properties of the material.
Peripheral artery disease dominated the application segment in 2023 due to geriatric population and increasing prevalence of the disease.
Based on application, coronary artery diseases segment were expected to grow at a significant rate during the forecast period due to being a major health concern in the U.S.
Hospitals occupied a larger share in end-use segment due to the increasing number of patient visiting the hospitals.
In terms of end-use, ambulatory service segment is expected to grow at the fastest CAGR over the forecast period.
In August 2023, DuPont, a global innovation leader with technology-based materials and solutions, completed its acquisition of Spectrum Plastics Group, a leading provider of high-value polymer solutions for medical devices and healthcare markets.
Grand View Research has segmented the U.S PTA balloon catheter market based on material, application, end-use, and region.
U.S. PTA Balloon Catheter Material Type Outlook (Revenue, USD Million, 2018 - 2030)
Polyurethane
Nylon
Others
U.S. PTA Balloon Catheter Application Outlook (Revenue, USD Million, 2018 - 2030)
Peripheral Artery Disease
Coronary Artery Disease
U.S. PTA Balloon Catheter End-use Outlook (Revenue, USD Million, 2018 - 2030)
Hospitals
Ambulatory Surgical Centers
Others
U.S. PTA Balloon Catheter Regional Outlook (Revenue, USD Million, 2018 - 2030)
West
Midwest
Northeast
Southwest
Southeast
List of Key Players in the U.S. PTA Balloon Catheter Market
Abbott
Andra Tec
Biotronik
Boston Scientific Corporation
Cardinal Health
Cook Group
Medtronic
Natec Medical
Terumo Corporation
"The quality of research they have done for us has been excellent..."